Literature DB >> 15483024

Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.

Suzanne E Little1, Sandra P Hanks, Linda King-Underwood, Chris Jones, Elizabeth A Rapley, Nazneen Rahman, Kathy Pritchard-Jones.   

Abstract

PURPOSE: Constitutional WT1 mutations in patients with Wilms' tumor (WT) have specifically been associated with genitourinary abnormalities, such as cryptorchidism and hypospadias. We sought to ascertain the frequency and heritability of constitutional WT1 mutations in nonsyndromic WT patients. PATIENTS AND METHODS: Constitutional DNA from 282 patients treated at seven United Kingdom Children's Cancer Study Group centers was screened for WT1 mutations using heteroduplex analysis. Bidirectional sequencing was used to confirm the mutation and to analyze the corresponding parental DNA samples.
RESULTS: Five different constitutional WT1 mutations were identified in six children. Mutations in four patients were confirmed to be de novo, and all five mutations are predicted to produce truncated protein. The WT1 mutation group had a young median age at diagnosis of 13.8 months, compared with 34.9 months in the group in whom no WT1 mutations were found; four were female and two were male; and all tumors were of favorable histology. The three tumors with known histologic subtype were stromal-predominant. Contrary to expectation, four of six mutations occurred in children with unilateral tumors without any associated genitourinary abnormality.
CONCLUSION: Constitutional WT1 mutations occur with a low frequency (2.1%; 95% CI, 0.8% to 4.6%) in nonsyndromic WT patients. Most mutations occurred in children with unilateral WT without associated genitourinary abnormalities, creating difficulties in identifying individuals with germline mutations on phenotype alone. Two factors that may indicate that an individual is carrying a germline WT1 mutation are an early age of onset and stromal-predominant histology of the WT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483024     DOI: 10.1200/JCO.2004.02.136

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  26 in total

Review 1.  Current management of wilms' tumor.

Authors:  Leah Nakamura; Michael Ritchey
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

2.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Authors:  Jane Lange; Susan M Peterson; Janice R Takashima; Yevgeny Grigoriev; Michael L Ritchey; Robert C Shamberger; J Bruce Beckwith; Elizabeth Perlman; Daniel M Green; Norman E Breslow
Journal:  J Urol       Date:  2011-06-17       Impact factor: 7.450

3.  Discordant expression of a new WT1 gene mutation in a family with monozygotic twins presenting with congenital nephrotic syndrome.

Authors:  Filip Fencl; Michal Malina; Veronika Stará; Jakub Zieg; Dana Mixová; Tomáš Seeman; Květa Bláhová
Journal:  Eur J Pediatr       Date:  2011-05-26       Impact factor: 3.183

Review 4.  Genetics of pediatric renal tumors.

Authors:  Brigitte Royer-Pokora
Journal:  Pediatr Nephrol       Date:  2012-03-30       Impact factor: 3.714

Review 5.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

6.  Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.

Authors:  Norman E Breslow; J Bruce Beckwith; Elizabeth J Perlman; Anthony E Reeve
Journal:  Pediatr Blood Cancer       Date:  2006-09       Impact factor: 3.167

7.  Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.

Authors:  Phoenix A Ho; Rong Zeng; Todd A Alonzo; Robert B Gerbing; Kristen L Miller; Jessica A Pollard; Derek L Stirewalt; Nyla A Heerema; Susana C Raimondi; Betsy Hirsch; Janet L Franklin; Beverly Lange; Soheil Meshinchi
Journal:  Blood       Date:  2010-04-22       Impact factor: 22.113

8.  A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.

Authors:  Fatemeh Abbaszadeh; Karen T Barker; Carmel McConville; Richard H Scott; Nazneen Rahman
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

9.  A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.

Authors:  Monica Terenziani; Michele Sardella; Beatrice Gamba; Maria Adele Testi; Filippo Spreafico; Gianluigi Ardissino; Fausto Fedeli; Franca Fossati-Bellani; Paolo Radice; Daniela Perotti
Journal:  Pediatr Nephrol       Date:  2008-12-02       Impact factor: 3.714

10.  Mutations in the transcriptional repressor REST predispose to Wilms tumor.

Authors:  Shazia S Mahamdallie; Sandra Hanks; Kristen L Karlin; Anna Zachariou; Elizabeth R Perdeaux; Elise Ruark; Chad A Shaw; Alexander Renwick; Emma Ramsay; Shawn Yost; Anna Elliott; Jillian Birch; Michael Capra; Juliet Gray; Juliet Hale; Judith Kingston; Gill Levitt; Thomas McLean; Eamonn Sheridan; Anthony Renwick; Sheila Seal; Charles Stiller; Neil Sebire; Thomas F Westbrook; Nazneen Rahman
Journal:  Nat Genet       Date:  2015-11-09       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.